MLN8237 (ALISERTIB), An Investigational Aurora a Kinase...

Annals of Oncology 2012 / 09 Vol. 23

MLN8237 (ALISERTIB), An Investigational Aurora a Kinase Inhibitor, in Patients (PTS) with Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Breast Cancer (BRC), Head and Neck Squamous Cell Carcinoma (HNSCC), And Gastroesophageal Cancer (GE): Emerging Phase (PH) 2 Results

Melichar, B., Lee, P., Alvarez, R.H., Degardin, M., Bennouna, J., Schusterbauer, C., Zhang, B., Benaim, E., Rosen, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)33020-9
Date:
September, 2012
File:
PDF, 64 KB
2012
Conversion to is in progress
Conversion to is failed